GLP3-RT 20mg

Description

GLP3-RT 20 mg — Mid-Scale Triple Agonist for Mechanism-of-Action Studies

GLP3-RT 20 mg provides an expanded quantity of this revolutionary triple-receptor agonist peptide, supporting mid-scale research programs that require substantial reagent volumes for dose-response analyses, mechanism-of-action studies, and comparative pharmacology experiments. GLP3-RT is distinguished from conventional single- and dual-target peptides by its engineered capacity to simultaneously activate GIP, incretin, and glucagon receptor subtypes — a pharmacological profile that has opened new avenues of investigation in metabolic signaling research and GPCR biology.

In cell-based functional assays, the 20 mg quantity enables researchers to construct complete efficacy and potency curves across multiple receptor-expressing cell lines in a single experimental campaign. Studies published in high-impact journals have characterized the receptor interaction profiles of GLP3-RT using radioligand displacement assays, fluorescent-based cAMP accumulation assays, and bioluminescence resonance energy transfer (BRET) techniques for measuring real-time receptor conformational changes. The glucagon receptor component adds an additional dimension of complexity not present in dual-agonist molecules, enabling the study of integrated metabolic consequences of simultaneous incretin and counter-regulatory hormone receptor activation.

The 20 mg format represents a practical balance between cost-effectiveness and experimental capacity for mid-stage research programs. Each lot is verified through HPLC, mass spectrometry, and amino acid analysis. Coffee & Pepper Peptides supplies this product as a research chemical for use by qualified investigators only. It is not approved for human or veterinary use.

FDA DISCLAIMER

The information provided on this website has not been evaluated by the U.S. Food and Drug Administration (FDA). None of the statements herein, nor any of the products offered, are intended to diagnose, treat, cure, or prevent any medical condition.

All products are supplied strictly as laboratory research reagents and are not for human consumption. We do not provide products to patients and do not make any claims regarding medical use.

Coffee & Pepper Peptides operates solely as a chemical supplier. It is not a compounding pharmacy and does not operate as a compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act.